Literature DB >> 20189952

Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.

Tarik Smani1, Eva Calderón-Sanchez, Nieves Gómez-Hurtado, María Fernández-Velasco, Victoria Cachofeiro, Vicente Lahera, Antonio Ordoñez, Carmen Delgado.   

Abstract

AIMS: The aim of this study was to elucidate the signalling pathways implicated in the modulation of cardiac L-type Ca(2+) channels by urocortin (Ucn) in ventricular myocytes. METHODS AND
RESULTS: Adult rat ventricular myocytes were stimulated in vitro with Ucn for 20-40 min. L-type calcium currents (I(CaL)) were measured with the patch-clamp technique, whereas quantification of activation of extracellular signal-regulated kinases 1/2 (ERK1/2) was assessed by sandwich-ELISA. Ucn induced a significant increase in I(CaL) density that was not prevented by the protein kinase A (PKA) inhibitor KT-5720 or the non-selective antagonist of guanine nucleotide exchange factor brefeldin A. The Ucn effect was antagonized by astressin, a corticotropin-releasing factor receptor-2 (CRF-R2) antagonist, and significantly reduced by protein kinase C (PKC) and ERK1/2 inhibitors. The cyclic AMP (cAMP) analogue 8-pCPT-2'OMe-cAMP, which selectively activates the exchange protein activated by cAMP (Epac), was ineffective in modifying I(CaL). Analysis of phospho-ERK1/2 showed that Ucn induced a significant activation of the ERK1/2 pathway in ventricular myocytes and this effect was prevented by pre-incubation with PKC inhibitors.
CONCLUSION: The present study provides evidence of new mechanisms involved in the modulation of L-type Ca(2+) channels by Ucn in adult ventricular myocytes. We propose that the marked increase in I(CaL) density induced by Ucn is mediated through CRF-R2 and involves PKC-dependent activation of the ERK1/2 pathway, whereas PKA and Epac signalling are not implicated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189952     DOI: 10.1093/cvr/cvq063

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

1.  Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor.

Authors:  Julia C Lemos; Jung Hoon Shin; Veronica A Alvarez
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

2.  Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury.

Authors:  Aseel Khalaf; Fawzi Babiker
Journal:  J Physiol Biochem       Date:  2016-06-21       Impact factor: 4.158

Review 3.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 4.  Redox control of cardiac excitability.

Authors:  Nitin T Aggarwal; Jonathan C Makielski
Journal:  Antioxid Redox Signal       Date:  2012-08-16       Impact factor: 8.401

5.  PKCβ/NF-κB pathway in diabetic atrial remodeling.

Authors:  Haili Wang; Yuanyuan Xu; Aiqing Xu; Xinghua Wang; Lijun Cheng; Sharen Lee; Gary Tse; Guangping Li; Tong Liu; Huaying Fu
Journal:  J Physiol Biochem       Date:  2020-10-21       Impact factor: 4.158

6.  Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.

Authors:  Stefanie Walther; Florentina Pluteanu; Susanne Renz; Yulia Nikonova; Joshua T Maxwell; Li-Zhen Yang; Kurt Schmidt; Joshua N Edwards; Paulina Wakula; Klaus Groschner; Lars S Maier; Joachim Spiess; Lothar A Blatter; Burkert Pieske; Jens Kockskämper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

7.  Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes.

Authors:  Sara Dizayee; Sonja Kaestner; Fabian Kuck; Peter Hein; Christoph Klein; Roland P Piekorz; Janos Meszaros; Jan Matthes; Lutz Bjrnbaumer; Bernd Nürnberg; Stefan Herzig
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

8.  DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy.

Authors:  Ruben Martín; Maria Miana; Raquel Jurado-López; Ernesto Martínez-Martínez; Nieves Gómez-Hurtado; Carmen Delgado; Maria Visitación Bartolomé; José Alberto San Román; Claudia Cordova; Vicente Lahera; Maria Luisa Nieto; Victoria Cachofeiro
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Corticotropin releasing factor excites neurons of posterior hypothalamic nucleus to produce tachycardia in rats.

Authors:  He-Ren Gao; Qian-Xing Zhuang; Bin Li; Hong-Zhao Li; Zhang-Peng Chen; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2.

Authors:  Eva Calderón-Sánchez; Ignacio Díaz; Antonio Ordóñez; Tarik Smani
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.